PubMed · 12515043
Prophylaxis against anthrax.
Abstract
The paper presents fundamental knowledge concerning Bacillus anthracis and its potential terrorist misuse. The basic clinical forms are resumed with emphasis on inhalation infection from inspiration of B. anthracis spores. The AVA vaccine licensed in the United States, primary vaccination, protective efficacy of the vaccine, and adverse events are characterised. Stress is laid on pre-exposure and post-exposure prophylaxis of anthrax.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Miroslav Splino, Jirí Patocka. 2002. Prophylaxis against anthrax.. https://pubmed.ncbi.nlm.nih.gov/12515043/
Cite the original work for its findings. Save a collection to share your selection of sources.